• レポートコード:GIR-203B15242 • 出版社/出版日:GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療装置 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
末梢薬被覆バルーン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の末梢薬被覆バルーンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx%の変化があります。世界の末梢薬被覆バルーンの市場規模は次の5年間でxxx%のCAGRで成長すると予想されます。 末梢薬被覆バルーン市場は種類と用途によって区分されます。2016年~2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・パクリタキセル、シロリムス、その他 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の末梢薬被覆バルーン市場の主要な市場プレーヤーは以下のとおりです。 ・Cordis、Defibtech、Abbott Laboratories、REVA Medical、Shimadzu、Opto Circuits、Biotronik、Endologix、SMT、Philips Healthcare、Elixir Medical、CorMatrix Cardiovascular、Advanced Cardiac Therapeutics、Edwards Lifesciences、Impulse Dynamics、Stereotaxis 地域別セグメントは次の地域・国をカバーします。 ・北米(米国、カナダ、メキシコ) ・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア) ・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア) ・南アメリカ(ブラジル、アルゼンチン、コロンビア) ・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ) 本調査レポートの内容は計14章あります。 ・第1章では、末梢薬被覆バルーン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な末梢薬被覆バルーンメーカーの企業概要、2019年~2021年までの末梢薬被覆バルーンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な末梢薬被覆バルーンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年~2026年までの地域別末梢薬被覆バルーンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年~2026年までの末梢薬被覆バルーンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年~2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年~2026年までの主要地域での末梢薬被覆バルーン市場予測を収録しています。 ・第12、13、14章では、末梢薬被覆バルーンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報(企業概要、製品概要、販売量、価格、売上):Cordis、Defibtech、Abbott Laboratories、REVA Medical、Shimadzu、Opto Circuits、Biotronik、Endologix、SMT、Philips Healthcare、Elixir Medical、CorMatrix Cardiovascular、Advanced Cardiac Therapeutics、Edwards Lifesciences、Impulse Dynamics、Stereotaxis ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:パクリタキセル、シロリムス、その他 ・用途別分析2016年-2026年:病院、クリニック、その他 ・末梢薬被覆バルーンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・末梢薬被覆バルーンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・末梢薬被覆バルーンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・末梢薬被覆バルーンの南米市場規模2016年-2026年:ブラジル、アルゼンチン ・末梢薬被覆バルーンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Peripheral Drug-Coated Balloon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Peripheral Drug-Coated Balloon size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Peripheral Drug-Coated Balloon market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Peripheral Drug-Coated Balloon market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Paclitaxel
Sirolimus
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Peripheral Drug-Coated Balloon market are listed below:
Cordis
Defibtech
Abbott Laboratories
REVA Medical
Shimadzu
Opto Circuits
Biotronik
Endologix
SMT
Philips Healthcare
Elixir Medical
CorMatrix Cardiovascular
Advanced Cardiac Therapeutics
Edwards Lifesciences
Impulse Dynamics
Stereotaxis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Peripheral Drug-Coated Balloon product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peripheral Drug-Coated Balloon, with price, sales, revenue and global market share of Peripheral Drug-Coated Balloon from 2019 to 2021.
Chapter 3, the Peripheral Drug-Coated Balloon competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peripheral Drug-Coated Balloon breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Peripheral Drug-Coated Balloon market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Peripheral Drug-Coated Balloon sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Peripheral Drug-Coated Balloon Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peripheral Drug-Coated Balloon Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Paclitaxel
1.2.3 Sirolimus
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Peripheral Drug-Coated Balloon Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Peripheral Drug-Coated Balloon Market Size & Forecast
1.4.1 Global Peripheral Drug-Coated Balloon Sales in Value (2016-2026))
1.4.2 Global Peripheral Drug-Coated Balloon Sales in Volume (2016-2026)
1.4.3 Global Peripheral Drug-Coated Balloon Price by Type (2016-2026) & (US$/Unit)
1.5 Global Peripheral Drug-Coated Balloon Production Capacity Analysis
1.5.1 Global Peripheral Drug-Coated Balloon Total Production Capacity (2016-2026)
1.5.2 Global Peripheral Drug-Coated Balloon Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peripheral Drug-Coated Balloon Market Drivers
1.6.2 Peripheral Drug-Coated Balloon Market Restraints
1.6.3 Peripheral Drug-Coated Balloon Trends Analysis
2 Manufacturers Profiles
2.1 Cordis
2.1.1 Cordis Details
2.1.2 Cordis Major Business
2.1.3 Cordis Peripheral Drug-Coated Balloon Product and Services
2.1.4 Cordis Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Defibtech
2.2.1 Defibtech Details
2.2.2 Defibtech Major Business
2.2.3 Defibtech Peripheral Drug-Coated Balloon Product and Services
2.2.4 Defibtech Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Product and Services
2.3.4 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 REVA Medical
2.4.1 REVA Medical Details
2.4.2 REVA Medical Major Business
2.4.3 REVA Medical Peripheral Drug-Coated Balloon Product and Services
2.4.4 REVA Medical Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Shimadzu
2.5.1 Shimadzu Details
2.5.2 Shimadzu Major Business
2.5.3 Shimadzu Peripheral Drug-Coated Balloon Product and Services
2.5.4 Shimadzu Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Opto Circuits
2.6.1 Opto Circuits Details
2.6.2 Opto Circuits Major Business
2.6.3 Opto Circuits Peripheral Drug-Coated Balloon Product and Services
2.6.4 Opto Circuits Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Biotronik
2.7.1 Biotronik Details
2.7.2 Biotronik Major Business
2.7.3 Biotronik Peripheral Drug-Coated Balloon Product and Services
2.7.4 Biotronik Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Endologix
2.8.1 Endologix Details
2.8.2 Endologix Major Business
2.8.3 Endologix Peripheral Drug-Coated Balloon Product and Services
2.8.4 Endologix Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 SMT
2.9.1 SMT Details
2.9.2 SMT Major Business
2.9.3 SMT Peripheral Drug-Coated Balloon Product and Services
2.9.4 SMT Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Philips Healthcare
2.10.1 Philips Healthcare Details
2.10.2 Philips Healthcare Major Business
2.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Product and Services
2.10.4 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Elixir Medical
2.11.1 Elixir Medical Details
2.11.2 Elixir Medical Major Business
2.11.3 Elixir Medical Peripheral Drug-Coated Balloon Product and Services
2.11.4 Elixir Medical Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 CorMatrix Cardiovascular
2.12.1 CorMatrix Cardiovascular Details
2.12.2 CorMatrix Cardiovascular Major Business
2.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product and Services
2.12.4 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Advanced Cardiac Therapeutics
2.13.1 Advanced Cardiac Therapeutics Details
2.13.2 Advanced Cardiac Therapeutics Major Business
2.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product and Services
2.13.4 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Edwards Lifesciences
2.14.1 Edwards Lifesciences Details
2.14.2 Edwards Lifesciences Major Business
2.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Product and Services
2.14.4 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Impulse Dynamics
2.15.1 Impulse Dynamics Details
2.15.2 Impulse Dynamics Major Business
2.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Product and Services
2.15.4 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Stereotaxis
2.16.1 Stereotaxis Details
2.16.2 Stereotaxis Major Business
2.16.3 Stereotaxis Peripheral Drug-Coated Balloon Product and Services
2.16.4 Stereotaxis Peripheral Drug-Coated Balloon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Peripheral Drug-Coated Balloon Sales by Manufacturer
3.1 Global Peripheral Drug-Coated Balloon Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Peripheral Drug-Coated Balloon Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Peripheral Drug-Coated Balloon
3.4 Market Concentration Rate
3.4.1 Top 3 Peripheral Drug-Coated Balloon Manufacturer Market Share
3.4.2 Top 6 Peripheral Drug-Coated Balloon Manufacturer Market Share
3.5 Global Peripheral Drug-Coated Balloon Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Peripheral Drug-Coated Balloon Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peripheral Drug-Coated Balloon Market Size by Region
4.1.1 Global Peripheral Drug-Coated Balloon Sales in Volume by Region (2016-2026)
4.1.2 Global Peripheral Drug-Coated Balloon Revenue by Region (2016-2026)
4.2 North America Peripheral Drug-Coated Balloon Revenue (2016-2026)
4.3 Europe Peripheral Drug-Coated Balloon Revenue (2016-2026)
4.4 Asia-Pacific Peripheral Drug-Coated Balloon Revenue (2016-2026)
4.5 South America Peripheral Drug-Coated Balloon Revenue (2016-2026)
4.6 Middle East and Africa Peripheral Drug-Coated Balloon Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Peripheral Drug-Coated Balloon Sales in Volume by Type (2016-2026)
5.2 Global Peripheral Drug-Coated Balloon Revenue by Type (2016-2026)
5.3 Global Peripheral Drug-Coated Balloon Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Peripheral Drug-Coated Balloon Sales in Volume by Application (2016-2026)
6.2 Global Peripheral Drug-Coated Balloon Revenue by Application (2016-2026)
6.3 Global Peripheral Drug-Coated Balloon Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Peripheral Drug-Coated Balloon Sales by Type (2016-2026)
7.2 North America Peripheral Drug-Coated Balloon Sales by Application (2016-2026)
7.3 North America Peripheral Drug-Coated Balloon Market Size by Country
7.3.1 North America Peripheral Drug-Coated Balloon Sales in Volume by Country (2016-2026)
7.3.2 North America Peripheral Drug-Coated Balloon Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Peripheral Drug-Coated Balloon Sales by Type (2016-2026)
8.2 Europe Peripheral Drug-Coated Balloon Sales by Application (2016-2026)
8.3 Europe Peripheral Drug-Coated Balloon Market Size by Country
8.3.1 Europe Peripheral Drug-Coated Balloon Sales in Volume by Country (2016-2026)
8.3.2 Europe Peripheral Drug-Coated Balloon Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Peripheral Drug-Coated Balloon Sales by Type (2016-2026)
9.2 Asia-Pacific Peripheral Drug-Coated Balloon Sales by Application (2016-2026)
9.3 Asia-Pacific Peripheral Drug-Coated Balloon Market Size by Region
9.3.1 Asia-Pacific Peripheral Drug-Coated Balloon Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Peripheral Drug-Coated Balloon Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Peripheral Drug-Coated Balloon Sales by Type (2016-2026)
10.2 South America Peripheral Drug-Coated Balloon Sales by Application (2016-2026)
10.3 South America Peripheral Drug-Coated Balloon Market Size by Country
10.3.1 South America Peripheral Drug-Coated Balloon Sales in Volume by Country (2016-2026)
10.3.2 South America Peripheral Drug-Coated Balloon Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type (2016-2026)
11.2 Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application (2016-2026)
11.3 Middle East & Africa Peripheral Drug-Coated Balloon Market Size by Country
11.3.1 Middle East & Africa Peripheral Drug-Coated Balloon Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Peripheral Drug-Coated Balloon Typical Distributors
12.3 Peripheral Drug-Coated Balloon Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Peripheral Drug-Coated Balloon Revenue by Type, (USD Million), 2021-2026
Table 2. Global Peripheral Drug-Coated Balloon Revenue by Application, (USD Million), 2021-2026
Table 3. Cordis Basic Information, Manufacturing Base and Competitors
Table 4. Cordis Major Business
Table 5. Cordis Peripheral Drug-Coated Balloon Product and Services
Table 6. Cordis Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Defibtech Basic Information, Manufacturing Base and Competitors
Table 8. Defibtech Major Business
Table 9. Defibtech Peripheral Drug-Coated Balloon Product and Services
Table 10. Defibtech Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Laboratories Major Business
Table 13. Abbott Laboratories Peripheral Drug-Coated Balloon Product and Services
Table 14. Abbott Laboratories Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. REVA Medical Basic Information, Manufacturing Base and Competitors
Table 16. REVA Medical Major Business
Table 17. REVA Medical Peripheral Drug-Coated Balloon Product and Services
Table 18. REVA Medical Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 20. Shimadzu Major Business
Table 21. Shimadzu Peripheral Drug-Coated Balloon Product and Services
Table 22. Shimadzu Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Opto Circuits Basic Information, Manufacturing Base and Competitors
Table 24. Opto Circuits Major Business
Table 25. Opto Circuits Peripheral Drug-Coated Balloon Product and Services
Table 26. Opto Circuits Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Biotronik Basic Information, Manufacturing Base and Competitors
Table 28. Biotronik Major Business
Table 29. Biotronik Peripheral Drug-Coated Balloon Product and Services
Table 30. Biotronik Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Endologix Basic Information, Manufacturing Base and Competitors
Table 32. Endologix Major Business
Table 33. Endologix Peripheral Drug-Coated Balloon Product and Services
Table 34. Endologix Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. SMT Basic Information, Manufacturing Base and Competitors
Table 36. SMT Major Business
Table 37. SMT Peripheral Drug-Coated Balloon Product and Services
Table 38. SMT Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 40. Philips Healthcare Major Business
Table 41. Philips Healthcare Peripheral Drug-Coated Balloon Product and Services
Table 42. Philips Healthcare Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Elixir Medical Basic Information, Manufacturing Base and Competitors
Table 44. Elixir Medical Major Business
Table 45. Elixir Medical Peripheral Drug-Coated Balloon Product and Services
Table 46. Elixir Medical Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. CorMatrix Cardiovascular Basic Information, Manufacturing Base and Competitors
Table 48. CorMatrix Cardiovascular Major Business
Table 49. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product and Services
Table 50. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Advanced Cardiac Therapeutics Basic Information, Manufacturing Base and Competitors
Table 52. Advanced Cardiac Therapeutics Major Business
Table 53. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product and Services
Table 54. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Edwards Lifesciences Basic Information, Manufacturing Base and Competitors
Table 56. Edwards Lifesciences Major Business
Table 57. Edwards Lifesciences Peripheral Drug-Coated Balloon Product and Services
Table 58. Edwards Lifesciences Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Impulse Dynamics Basic Information, Manufacturing Base and Competitors
Table 60. Impulse Dynamics Major Business
Table 61. Impulse Dynamics Peripheral Drug-Coated Balloon Product and Services
Table 62. Impulse Dynamics Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Stereotaxis Basic Information, Manufacturing Base and Competitors
Table 64. Stereotaxis Major Business
Table 65. Stereotaxis Peripheral Drug-Coated Balloon Product and Services
Table 66. Stereotaxis Peripheral Drug-Coated Balloon Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Peripheral Drug-Coated Balloon Sales by Manufacturer (2019-2021e) & (K Units)
Table 68. Global Peripheral Drug-Coated Balloon Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Peripheral Drug-Coated Balloon, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Peripheral Drug-Coated Balloon Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Peripheral Drug-Coated Balloon Production Site of Key Manufacturer
Table 72. Peripheral Drug-Coated Balloon New Entrant and Capacity Expansion Plans
Table 73. Peripheral Drug-Coated Balloon Mergers & Acquisitions in the Past Five Years
Table 74. Global Peripheral Drug-Coated Balloon Sales by Region (2016-2021e) & (K Units)
Table 75. Global Peripheral Drug-Coated Balloon Sales by Region (2021-2026) & (K Units)
Table 76. Global Peripheral Drug-Coated Balloon Revenue by Region (2016-2021e) & (USD Million)
Table 77. Global Peripheral Drug-Coated Balloon Revenue by Region (2021-2026) & (USD Million)
Table 78. Global Peripheral Drug-Coated Balloon Sales by Type (2016-2021e) & (K Units)
Table 79. Global Peripheral Drug-Coated Balloon Sales by Type (2021-2026) & (K Units)
Table 80. Global Peripheral Drug-Coated Balloon Revenue by Type (2016-2021e) & (USD Million)
Table 81. Global Peripheral Drug-Coated Balloon Revenue by Type (2021-2026) & (USD Million)
Table 82. Global Peripheral Drug-Coated Balloon Price by Type (2016-2021e) & (US$/Unit)
Table 83. Global Peripheral Drug-Coated Balloon Price by Type (2021-2026) & (US$/Unit)
Table 84. Global Peripheral Drug-Coated Balloon Sales by Application (2016-2021e) & (K Units)
Table 85. Global Peripheral Drug-Coated Balloon Sales by Application (2021-2026) & (K Units)
Table 86. Global Peripheral Drug-Coated Balloon Revenue by Application (2016-2021e) & (USD Million)
Table 87. Global Peripheral Drug-Coated Balloon Revenue by Application (2021-2026) & (USD Million)
Table 88. Global Peripheral Drug-Coated Balloon Price by Application (2016-2021e) & (US$/Unit)
Table 89. Global Peripheral Drug-Coated Balloon Price by Application (2021-2026) & (US$/Unit)
Table 90. North America Peripheral Drug-Coated Balloon Sales by Country (2016-2021e) & (K Units)
Table 91. North America Peripheral Drug-Coated Balloon Sales by Country (2021-2026) & (K Units)
Table 92. North America Peripheral Drug-Coated Balloon Revenue by Country (2016-2021e) & (USD Million)
Table 93. North America Peripheral Drug-Coated Balloon Revenue by Country (2021-2026) & (USD Million)
Table 94. North America Peripheral Drug-Coated Balloon Sales by Type (2016-2021e) & (K Units)
Table 95. North America Peripheral Drug-Coated Balloon Sales by Type (2021-2026) & (K Units)
Table 96. North America Peripheral Drug-Coated Balloon Sales by Application (2016-2021e) & (K Units)
Table 97. North America Peripheral Drug-Coated Balloon Sales by Application (2021-2026) & (K Units)
Table 98. Europe Peripheral Drug-Coated Balloon Sales by Country (2016-2021e) & (K Units)
Table 99. Europe Peripheral Drug-Coated Balloon Sales by Country (2021-2026) & (K Units)
Table 100. Europe Peripheral Drug-Coated Balloon Revenue by Country (2016-2021e) & (USD Million)
Table 101. Europe Peripheral Drug-Coated Balloon Revenue by Country (2021-2026) & (USD Million)
Table 102. Europe Peripheral Drug-Coated Balloon Sales by Type (2016-2021e) & (K Units)
Table 103. Europe Peripheral Drug-Coated Balloon Sales by Type (2021-2026) & (K Units)
Table 104. Europe Peripheral Drug-Coated Balloon Sales by Application (2016-2021e) & (K Units)
Table 105. Europe Peripheral Drug-Coated Balloon Sales by Application (2021-2026) & (K Units)
Table 106. Asia-Pacific Peripheral Drug-Coated Balloon Sales by Region (2016-2021e) & (K Units)
Table 107. Asia-Pacific Peripheral Drug-Coated Balloon Sales by Region (2021-2026) & (K Units)
Table 108. Asia-Pacific Peripheral Drug-Coated Balloon Revenue by Region (2016-2021e) & (USD Million)
Table 109. Asia-Pacific Peripheral Drug-Coated Balloon Revenue by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Peripheral Drug-Coated Balloon Sales by Type (2016-2021e) & (K Units)
Table 111. Asia-Pacific Peripheral Drug-Coated Balloon Sales by Type (2021-2026) & (K Units)
Table 112. Asia-Pacific Peripheral Drug-Coated Balloon Sales by Application (2016-2021e) & (K Units)
Table 113. Asia-Pacific Peripheral Drug-Coated Balloon Sales by Application (2021-2026) & (K Units)
Table 114. South America Peripheral Drug-Coated Balloon Sales by Country (2016-2021e) & (K Units)
Table 115. South America Peripheral Drug-Coated Balloon Sales by Country (2021-2026) & (K Units)
Table 116. South America Peripheral Drug-Coated Balloon Revenue by Country (2016-2021e) & (USD Million)
Table 117. South America Peripheral Drug-Coated Balloon Revenue by Country (2021-2026) & (USD Million)
Table 118. South America Peripheral Drug-Coated Balloon Sales by Type (2016-2021e) & (K Units)
Table 119. South America Peripheral Drug-Coated Balloon Sales by Type (2021-2026) & (K Units)
Table 120. South America Peripheral Drug-Coated Balloon Sales by Application (2016-2021e) & (K Units)
Table 121. South America Peripheral Drug-Coated Balloon Sales by Application (2021-2026) & (K Units)
Table 122. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2016-2021e) & (K Units)
Table 123. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2021-2026) & (K Units)
Table 124. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2016-2021e) & (USD Million)
Table 125. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2021-2026) & (USD Million)
Table 126. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type (2016-2021e) & (K Units)
Table 127. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Type (2021-2026) & (K Units)
Table 128. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application (2016-2021e) & (K Units)
Table 129. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Application (2021-2026) & (K Units)
Table 130. Direct Channel Pros & Cons
Table 131. Indirect Channel Pros & Cons
Table 132. Peripheral Drug-Coated Balloon Typical Distributors
Table 133. Peripheral Drug-Coated Balloon Typical Customers
List of Figures
Figure 1. Peripheral Drug-Coated Balloon Picture
Figure 2. Global Peripheral Drug-Coated Balloon Sales Market Share by Type in 2020
Figure 3. Paclitaxel
Figure 4. Sirolimus
Figure 5. Others
Figure 6. Global Peripheral Drug-Coated Balloon Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Global Peripheral Drug-Coated Balloon Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Peripheral Drug-Coated Balloon Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Peripheral Drug-Coated Balloon Sales (2016-2026) & (K Units)
Figure 13. Global Peripheral Drug-Coated Balloon Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global Peripheral Drug-Coated Balloon Production Capacity (2016-2026) & (K Units)
Figure 15. Global Peripheral Drug-Coated Balloon Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Peripheral Drug-Coated Balloon Market Drivers
Figure 17. Peripheral Drug-Coated Balloon Market Restraints
Figure 18. Peripheral Drug-Coated Balloon Market Trends
Figure 19. Global Peripheral Drug-Coated Balloon Sales Market Share by Manufacturer in 2020
Figure 20. Global Peripheral Drug-Coated Balloon Revenue Market Share by Manufacturer in 2020
Figure 21. Peripheral Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Peripheral Drug-Coated Balloon Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Peripheral Drug-Coated Balloon Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2016-2026)
Figure 25. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2016-2026)
Figure 26. North America Peripheral Drug-Coated Balloon Revenue (2016-2026) & (USD Million)
Figure 27. Europe Peripheral Drug-Coated Balloon Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Peripheral Drug-Coated Balloon Revenue (2016-2026) & (USD Million)
Figure 29. South America Peripheral Drug-Coated Balloon Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Peripheral Drug-Coated Balloon Revenue (2016-2026) & (USD Million)
Figure 31. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2026)
Figure 32. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2016-2026)
Figure 33. Global Peripheral Drug-Coated Balloon Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2026)
Figure 35. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2016-2026)
Figure 36. Global Peripheral Drug-Coated Balloon Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2026)
Figure 38. North America Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2026)
Figure 39. North America Peripheral Drug-Coated Balloon Sales Market Share by Country (2016-2026)
Figure 40. North America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2016-2026)
Figure 41. United States Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2026)
Figure 45. Europe Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2026)
Figure 46. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country (2016-2026)
Figure 47. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country (2016-2026)
Figure 48. Germany Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Peripheral Drug-Coated Balloon Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Peripheral Drug-Coated Balloon Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Peripheral Drug-Coated Balloon Revenue Market Share by Region (2016-2026)
Figure 57. China Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2026)
Figure 64. South America Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2026)
Figure 65. South America Peripheral Drug-Coated Balloon Sales Market Share by Country (2016-2026)
Figure 66. South America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Peripheral Drug-Coated Balloon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source